Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.

Voysey M. et al, (2021), Lancet, 397, 881 - 891

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial

Ramasamy MN. et al, (2021), Lancet, 396, 1979 - 1993

T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a Phase 1/2 clinical trial.

LAMBE T. et al, (2020), Nature Medicine

Mycobacterium tuberculosis-specific cytokine biomarkers to differentiate active TB and LTBI: A systematic review.

Sudbury EL. et al, (2020), J Infect

COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study

Götzinger F. et al, (2020), The Lancet Child & Adolescent Health, 4, 653 - 661

Clinical characteristics and diagnostic test performance among children evaluated for tuberculosis in Kenya

Click E. and SONG R., (2020)

COVID-19 in children and adolescents in Europe – a multinational multi-center Paediatric Tuberculosis Network European Trials Group (ptbnet) study

Goetzinger F. et al, (2020)

Sensitive and feasible specimen collection and testing strategies for diagnosing tuberculosis in young children

SONG R. and Click E., (2020)

Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses

Barrett JR. et al, (2020), Nat Med

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Voysey M. et al, (2020), Lancet

Advanced immunodiagnostic tests for paediatric tuberculosis.

Villanueva P. et al, (2019), Lancet Infect Dis, 19, 467 - 468

Development of colorimetric sensor array for diagnosis of tuberculosis through detection of urinary volatile organic compounds

Sandlund J. et al, (2018), Diagnostic Microbiology and Infectious Disease, 92, 299 - 304

Commercial products to preserve specimens for tuberculosis diagnosis: a systematic review.

Reeve BWP. et al, (2018), The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 22, 741 - 753

Computer-aided reading of tuberculosis chest radiography: moving the research agenda forward to inform policy

Ahmad Khan F. et al, (2017), European Respiratory Journal, 50, 1700953 - 1700953

A Blueprint to Address Research Gaps in the Development of Biomarkers for Pediatric Tuberculosis: Table 1.

Nicol MP. et al, (2015), Clinical Infectious Diseases, 61, S164 - S172

Treatment for LTBI in contacts of MDR-TB patients, Federated States of Micronesia, 2009–2012

Bamrah S. et al, (2014), The International Journal of Tuberculosis and Lung Disease, 18, 912 - 918

Include forthcoming?